Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Cash from Financing Activities (2016 - 2025)

Jaguar Health (JAGX) has disclosed Cash from Financing Activities for 11 consecutive years, with $9.8 million as the latest value for Q4 2025.

  • Quarterly Cash from Financing Activities rose 245.94% to $9.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $23.7 million through Dec 2025, down 24.14% year-over-year, with the annual reading at $23.7 million for FY2025, 24.14% down from the prior year.
  • Cash from Financing Activities for Q4 2025 was $9.8 million at Jaguar Health, up from $6.3 million in the prior quarter.
  • The five-year high for Cash from Financing Activities was $30.9 million in Q1 2021, with the low at $373000.0 in Q3 2021.
  • Average Cash from Financing Activities over 5 years is $7.8 million, with a median of $5.6 million recorded in 2025.
  • The sharpest move saw Cash from Financing Activities skyrocketed 2620.38% in 2022, then plummeted 86.11% in 2023.
  • Over 5 years, Cash from Financing Activities stood at $3.1 million in 2021, then crashed by 47.52% to $1.6 million in 2022, then surged by 550.18% to $10.6 million in 2023, then crashed by 73.43% to $2.8 million in 2024, then surged by 245.94% to $9.8 million in 2025.
  • According to Business Quant data, Cash from Financing Activities over the past three periods came in at $9.8 million, $6.3 million, and $2.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.